Integra LifeSciences Raises $450M in 9.5% Senior Secured Notes to Strengthen Capital for 2033
Integra LifeSciences secures $450 M in 9.50% senior secured notes to refinance debt, boost yields, and fund innovation in orthopedic and neurosurgical markets.
2 minutes to read